CHMP Grants Positive Opinion for Expanded Use of Otsuka’s Deltyba® (delamanid) in Children and Adole

Updated: Oct 4

The European Medicines Agency has updated its stance on Deltyba—with implications for children with DR-TB.
Read about it here.
1 view

Recent Posts

See All


© 2023 by Last Chance. Proudly created with